Literature DB >> 2384110

Persistent chest pain following oral dipyridamole for thallium 201 myocardial imaging.

A H Kwai1, A F Jacobson, K M McIntyre, W H Williams, D E Tow.   

Abstract

A patient was admitted to the hospital with acute chest pain. After acute myocardial infarction was ruled out, he underwent a stress thallium 201 scintigraphy using oral dipyridamole and developed persistent angina with ST-segment elevation. This complication has not been reported previously. It is recommended that appropriate intervention be available if severe ischemia develops following administration of dipyridamole for diagnostic imaging.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2384110     DOI: 10.1007/bf00998182

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  5 in total

1.  Clinical decision making: dipyridamole thallium imaging.

Authors:  J B Gill; D D Miller; C A Boucher; H W Strauss
Journal:  J Nucl Med       Date:  1986-01       Impact factor: 10.057

2.  Thallium-201 myocardial imaging during coronary vasodilation induced by oral dipyridamole.

Authors:  K L Gould; S G Sorenson; P Albro; J H Caldwell; T Chaudhuri; G W Hamilton
Journal:  J Nucl Med       Date:  1986-01       Impact factor: 10.057

3.  Inhibition of coronary vasodilating action of dipyridamole and adenosine by aminophylline in the dog.

Authors:  S Afonso
Journal:  Circ Res       Date:  1970-06       Impact factor: 17.367

4.  Effects of dipyridamole-induced vasodilation on myocardial uptake and clearance kinetics of thallium-201.

Authors:  G A Beller; H H Holzgrefe; D D Watson
Journal:  Circulation       Date:  1983-12       Impact factor: 29.690

5.  Usefulness of oral dipyridamole suspension for stress thallium imaging without exercise in the detection of coronary artery disease.

Authors:  S Homma; R J Callahan; B Ameer; K A McKusick; H W Strauss; R D Okada; C A Boucher
Journal:  Am J Cardiol       Date:  1986-03-01       Impact factor: 2.778

  5 in total
  4 in total

1.  Cardiogenic shock after dipyridamole administration for myocardial perfusion imaging.

Authors:  Fahim H Jafary; Nageeb Basir; Adnan Amin; Nasiruddin Ahmed
Journal:  J Nucl Cardiol       Date:  2005 May-Jun       Impact factor: 5.952

2.  Coronary steal and ST elevation during dipyridamole stress testing leading to coronary artery bypass grafting.

Authors:  Halil Mutlu; Jeffrey Leppo
Journal:  J Nucl Cardiol       Date:  2007-10-18       Impact factor: 5.952

Review 3.  Adenosine. An evaluation of its use in cardiac diagnostic procedures, and in the treatment of paroxysmal supraventricular tachycardia.

Authors:  D Faulds; P Chrisp; M M Buckley
Journal:  Drugs       Date:  1991-04       Impact factor: 9.546

4.  Safety of dipyridamole testing in 73,806 patients: the Multicenter Dipyridamole Safety Study.

Authors:  J Lette; J L Tatum; S Fraser; D D Miller; D D Waters; G Heller; E B Stanton; H S Bom; J Leppo; S Nattel
Journal:  J Nucl Cardiol       Date:  1995 Jan-Feb       Impact factor: 5.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.